Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma

Fig. 5

Low expression of BTNL9 significantly enriches proteasome and promotes tumor malignancy in LUAD. (A, B, C, D) High and low BTNL9 expression groups were presented using the Sangerbox tool and GSEA for KEGG and HALLMARK pathways. (E) the t-SNE plot shows scRNA analysis of BTNL9 expression, and (F) molecular function of BTNL9 in LUAD using CancerSEA database shows that BTNL9 is significantly negatively correlated with tumor invasion, metastasis, EMT, proliferation, hypoxia, and DNA damage in LUAD

Back to article page